Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -243,500 | 256,400 | 3,919,400 | 4,548,700 | -753,900 |
| Depreciation Amortization | 3,367,900 | 1,686,600 | 7,486,500 | 5,685,700 | 3,718,000 |
| Income taxes - deferred | -327,100 | -519,200 | -7,380,100 | -7,470,900 | -588,900 |
| Accounts receivable | -501,200 | -148,600 | -1,034,300 | -364,000 | -896,100 |
| Other Working Capital | -760,100 | -357,700 | -1,272,200 | -1,053,000 | -1,205,100 |
| Other Operating Activity | 1,096,900 | 335,600 | 2,886,800 | 1,628,000 | 1,652,300 |
| Operating Cash Flow | $2,632,900 | $1,253,100 | $4,606,100 | $2,974,500 | $1,926,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 25,500 | N/A | N/A | N/A | N/A |
| PPE Investments | -168,300 | -72,800 | -314,800 | -217,100 | -166,700 |
| Net Acquisitions | N/A | N/A | -37,510,100 | -35,242,700 | -35,109,900 |
| Purchase Of Investment | 0 | 0 | -24,300 | N/A | -21,000 |
| Sale Of Investment | N/A | 19,000 | 883,000 | 855,800 | N/A |
| Purchase Sale Intangibles | 0 | 0 | -154,700 | -118,100 | -28,500 |
| Other Investing Activity | 0 | 0 | -154,700 | -118,100 | 827,300 |
| Investing Cash Flow | $-142,800 | $-53,800 | $-37,120,900 | $-34,722,100 | $-34,470,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -2,935,600 | 900,000 | 30,137,700 | 29,338,400 | 29,338,400 |
| Debt Repayment | -63,800 | -854,200 | -5,134,200 | N/A | -4,096,200 |
| Common Stock Issued | 107,300 | 69,600 | 4,301,100 | 4,266,900 | 4,179,300 |
| Common Stock Repurchased | -67,300 | -53,200 | -118,000 | -108,200 | -101,000 |
| Dividend Paid | -139,200 | -69,600 | -208,100 | -138,400 | -68,700 |
| Other Financing Activity | 0 | -32,300 | 4,388,800 | 207,900 | 4,563,200 |
| Financing Cash Flow | $-3,098,600 | $-39,700 | $33,367,300 | $33,566,600 | $33,815,000 |
| Exchange Rate Effect | 2,000 | 5,200 | -6,500 | -5,100 | -3,100 |
| Beginning Cash Position | 1,096,000 | 1,096,000 | 250,000 | 250,000 | 250,000 |
| End Cash Position | 489,500 | 2,260,800 | 1,096,000 | 2,063,900 | 1,517,900 |
| Net Cash Flow | $-606,500 | $1,164,800 | $846,000 | $1,813,900 | $1,267,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,632,900 | 1,253,100 | 4,606,100 | 2,974,500 | 1,926,300 |
| Capital Expenditure | -182,800 | -84,900 | -454,900 | -350,700 | -248,200 |
| Free Cash Flow | 2,450,100 | 1,168,200 | 4,151,200 | 2,623,800 | 1,678,100 |